NeuroFrontiers
Clinical research and advancements furthering clinicians’ ability to diagnose and treat neurological disorders never stop. And neither does NeuroFrontiers, a series dedicated to covering them all. Here neurology specialists will find essential updates on conditions affecting the nervous system, spinal cord, and overall brain health.
So if you want to stay up to date on the latest clinical research and news on neurological disorders, then look no further. Because NeuroFrontiers is where neurology specialists and great minds explore the mind itself.
- Update frequency
- every 3 days
- Episodes
- 369
- Years Active
- 2008 - 2025
MS Research: Using Epigenetic Clocks and Biomarkers to Assess Biological Aging
Chronological age is the biggest early driver of disease progression in patients with multiple sclerosis (MS). That’s why a team of researchers wanted to explore whet…
Toxic Short RNAs May Cause Neuronal Cell Death in Alzheimer’s Disease
Guest: Marcus E. Peter, PhD
Death induced by survival gene elimination (DISE) is a cell death mechanism mediated by short RNAs. And according to a re…
Toxic Short RNAs May Cause Neuronal Cell Death in Alzheimer’s Disease
Guest: Marcus E. Peter, PhD
Death induced by survival gene elimination (DISE) is a cell death mechanism mediated by short RNAs. And according to a re…
Schizophrenia Diagnosis: The Importance of a Collaborative Approach
Guest: Morris Goldman, MD
Guest: Dara Sanandaji
A diagnosis of schizophrenia can be distressing, making clinical interventions crucial for both the pa…
Schizophrenia Diagnosis: The Importance of a Collaborative Approach
Guest: Morris Goldman, MD
Guest: Dara Sanandaji
A diagnosis of schizophrenia can be distressing, making clinical interventions crucial for both the pa…
A Successful and Safe Stem Cell Therapy for Progressive MS
Guest: Stefano Pluchino, MD, PhD
An international collaborative phase 1 study has shown that the injection of a specific form of stem cells into…
New Study Shows EBV-Specific T-Cells Contribute to MS Development
Epstein-Barr virus (EBV) has long been associated with multiple sclerosis (MS), but a recent study from UTHealth Houston has shed light on its role in the developm…
Examining the Role of Toxic Tau Proteins in Alzheimer's Disease
Guest: George Bloom, PhD
Toxic tau protein refers to an aberrant form of the tau protein in the brain, commonly associated with Alzheimer's disease, …
A Successful and Safe Stem Cell Therapy for Progressive MS
Guest: Stefano Pluchino, MD, PhD
An international collaborative phase 1 study has shown that the injection of a specific form of stem cells into…
New Study Shows EBV-Specific T-Cells Contribute to MS Development
Epstein-Barr virus (EBV) has long been associated with multiple sclerosis (MS), but a recent study from UTHealth Houston has shed light on its role in the developm…
Examining the Role of Toxic Tau Proteins in Alzheimer's Disease
Guest: George Bloom, PhD
Toxic tau protein refers to an aberrant form of the tau protein in the brain, commonly associated with Alzheimer's disease, …
Alzheimer’s Research: Opening the Blood-Brain Barrier with Aducanumab and Focused Ultrasound
Guest: Marc Haut, PhD
A recent phase 1 study investigated the safety and feasibility of combining focused ultrasound and aducanumab, which is a monoc…
PBA Treatment May Reverse Signs of Alzheimer’s Disease
Guest: Jini Naidoo, PhD
According to new research featured in Aging Biology, a treatment involvi…
PBA Treatment May Reverse Signs of Alzheimer’s Disease
Guest: Jini Naidoo, PhD
According to new research featured in Aging Biology, a treatment involvi…
Alzheimer’s Research: Opening the Blood-Brain Barrier with Aducanumab and Focused Ultrasound
Guest: Marc Haut, PhD
A recent phase 1 study investigated the safety and feasibility of combining focused ultrasound and aducanumab, which is a monoc…
First Episode Psychosis: Improving Patient Outcomes Through Early Intervention
Guest: Hannah Brown, MD
Unfortunately, when it comes to the diagnosis and treatment of schizophrenia, there is nothing to definitively give clinicians a d…
First Episode Psychosis: Improving Patient Outcomes Through Early Intervention
Guest: Hannah Brown, MD
Unfortunately, when it comes to the diagnosis and treatment of schizophrenia, there is nothing to definitively give clinicians a d…
Investigating the Clinical Utility of the Multiple Sclerosis Disease Activity Test
Guest: William A. Kilgo, MD
According to new research featured at the joint ECTRIMS-ACTRIMS meeting, the Multiple Sclerosis Disease Activity (MSDA) T…
Investigating the Clinical Utility of the Multiple Sclerosis Disease Activity Test
Guest: William A. Kilgo, MD
According to new research featured at the joint ECTRIMS-ACTRIMS meeting, the Multiple Sclerosis Disease Activity (MSDA) T…
Adverse Childhood and Lifespan Stressors Take a Toll on MS Disease Severity
Guest: Carri Polick, PhD, RN
Two recent studies linked childhood stress and stressors experienced across the lifespan to the severity of multiple scl…